Interleukin-2 gene therapy (Transgene)

N/A

Report date: 2023/10/26 16:02:17

Base Information

Drug NameInterleukin-2 gene therapy (Transgene)
Drug Alias NameAdeno-IL2TG 1024Ad-IL2Vero-IL-2TG-1024
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionIL2 gene transference
TargetsInterleukin-2
Therapy Area/IndicationsLung NeoplasmsGastrointestinal NeoplasmsCarcinoma, Renal Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene Sa
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsGastrointestinal NeoplasmsCarcinoma, Renal Cell +[5] 

Other Information

ATC CodeN/A
Related LinksN/A